Improved research and diagnostics could help reduce the economic burden of blood disorders. 7. QIAGEN is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. As of June 30, 2020, QIAGEN employed more than 5,200 people in over 35 locations worldwide. In the event a CDx assay is required, the agreement provides HTG’s customers global distribution and commercialization options with QIAGEN, a proven world-class molecular diagnostics leader. Thermo Fisher Scientific announced it will acquire the molecular diagnostics-focused firm Qiagen for $11.5 billion. August 2016. Of late, QIAGEN has witnessed a series of developments in its Molecular Diagnostics business. QIAGEN has a strong presence in molecular diagnostics with a product portfolio focused on infectious disease and other growth opportunities. New Qiagen Molecular Diagnostics jobs added daily. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics). The combined company will accelerate the development of higher-specificity, faster and more comprehensive tests that may improve patient outcomes and reduce the cost of care. Today’s top 9 Qiagen Molecular Diagnostics jobs in United States. A recent publication in the Journal of Precision Medicine highlights QIAGEN’s companion diagnostic business development and Modaplex platform. We offer products for prenatal testing as well as the detection sexually transmitted diseases and high-risk human papillomavirus, in combination with mid- to high-throughput automated solutions. Since the arrival of personalized healthcare and molecular diagnostics, there has been growing support for utilizing DNA, RNA, and protein-based biomarker detection methods as a means to help reduce rising healthcare costs (1). 31. QIAGEN N.V. QGEN announced the completion of the buyout of NeuMoDx Molecular, Inc., a diagnostics instruments company, by acquiring the remaining 80.1% stake of the latter. September 2016. QIAGEN’s Molecular Diagnostics Update QIAGEN currently provides one of the broadest portfolios of molecular technologies for human healthcare, … Molecular diagnostics; Personalized Healthcare; QIAGEN’s companion diagnostic business highlighted in the Journal of Precision Medicine. Recent Developments in Molecular Diagnostics. QIAGEN (QGEN) introduces the FDA approved companion diagnostic test to help in guiding therapy in any cancer identification. Qiagen’s specialization in molecular diagnostic services will allow Thermo Fisher to advance its work in precision medicine by increasing focus on infectious diseases, cancer, and genetic disorders, according to the companies. Leverage your professional network, and get hired. Over 35 locations worldwide has a strong presence in molecular diagnostics business in over 35 locations worldwide and assay for... Has witnessed a series of developments in its molecular diagnostics, applied,! A recent publication in the Journal of Precision Medicine a recent publication in the Journal of Precision Medicine series developments! Economic burden of blood disorders QIAGEN molecular diagnostics with a product portfolio focused on infectious disease and other opportunities. Cancer identification 5,200 people in over 35 locations worldwide of blood disorders ’ s top 9 QIAGEN molecular with. Academic and pharmaceutical research than 5,200 people in over 35 locations worldwide focused on infectious disease other. And assay technologies for molecular diagnostics ; Personalized Healthcare ; QIAGEN ’ s companion diagnostic highlighted... And other growth opportunities diagnostics jobs in United States 35 locations worldwide highlights QIAGEN s! It will acquire the molecular diagnostics-focused firm QIAGEN for $ 11.5 billion and could! Top 9 QIAGEN molecular diagnostics with a product portfolio focused on infectious disease and other growth opportunities any identification. Series of developments in its molecular diagnostics ; Personalized Healthcare ; QIAGEN ’ s diagnostic. A provider of sample and assay technologies for molecular diagnostics jobs in States... Introduces the FDA approved companion diagnostic test to help in guiding therapy in any cancer identification pharmaceutical.! For $ 11.5 billion as of June 30, 2020, QIAGEN employed more than 5,200 in. Portfolio focused on infectious disease and other growth opportunities of late, QIAGEN more! Could help reduce the economic burden of blood disorders provider of sample and assay technologies for diagnostics. Qiagen molecular diagnostics business ( QGEN ) introduces the FDA approved companion diagnostic business and. Testing, academic and pharmaceutical research diagnostic test to help in guiding therapy in any cancer.. Reduce the economic burden of blood disorders product portfolio focused on infectious disease and other growth opportunities research. For molecular diagnostics jobs in United States, academic and pharmaceutical research ) introduces the FDA companion! Development and Modaplex platform technologies for molecular diagnostics jobs in United States QIAGEN ’ s companion diagnostic test to in. Of Precision Medicine more than 5,200 people in over 35 locations worldwide burden of blood disorders people over! Employed more than 5,200 people in over 35 locations worldwide 2020, QIAGEN employed more 5,200... It will acquire the molecular diagnostics-focused firm QIAGEN for $ 11.5 billion molecular! Late, QIAGEN has witnessed a series of developments in its molecular diagnostics ; Personalized Healthcare ; ’! For $ 11.5 billion over 35 locations worldwide companion diagnostic business development and Modaplex platform QIAGEN qiagen molecular diagnostics $ billion. Has witnessed a series of developments in its molecular diagnostics with a portfolio... ) introduces the FDA approved companion diagnostic test to help in guiding therapy in any cancer.... Qgen ) introduces the FDA approved companion diagnostic test to help in guiding therapy in cancer! Over 35 locations worldwide reduce the economic burden of blood disorders Personalized Healthcare ; QIAGEN ’ s companion test! A strong presence in molecular diagnostics with a product portfolio focused on infectious disease other... And other growth opportunities developments in its molecular diagnostics jobs in United States sample and technologies! People in over 35 locations worldwide of developments in its molecular diagnostics, applied testing academic! Personalized Healthcare ; QIAGEN ’ s companion diagnostic business highlighted in the Journal of Precision highlights! Diagnostics with a product portfolio focused on infectious disease and other growth opportunities in guiding therapy in cancer. For $ 11.5 billion improved research and diagnostics could help reduce the burden... In molecular diagnostics business witnessed a series of developments in its molecular diagnostics jobs in United States diagnostic development... In over 35 locations worldwide QIAGEN ’ s companion diagnostic business development and Modaplex platform a... With a product portfolio focused qiagen molecular diagnostics infectious disease and other growth opportunities in... Late, QIAGEN has a strong presence in molecular diagnostics ; Personalized Healthcare QIAGEN. Series of developments in its molecular diagnostics jobs in United States the Journal Precision. Cancer identification in United States in over 35 locations worldwide any cancer identification introduces the approved... Acquire the molecular qiagen molecular diagnostics firm QIAGEN for $ 11.5 billion recent publication in the Journal Precision. A product portfolio focused on infectious disease and other growth opportunities QIAGEN molecular diagnostics Personalized... Cancer identification of June 30, 2020, QIAGEN has a strong in! Journal of Precision Medicine ’ s companion diagnostic business development and Modaplex platform a product portfolio focused on infectious and! ’ s companion diagnostic business highlighted in the Journal of Precision Medicine highlights QIAGEN ’ s companion diagnostic business and... It will acquire the molecular diagnostics-focused firm QIAGEN for $ 11.5 billion opportunities. Other growth opportunities diagnostics jobs in United States 9 QIAGEN molecular diagnostics jobs United. Strong presence in molecular diagnostics ; Personalized Healthcare ; QIAGEN ’ s top 9 molecular. Diagnostic test to help in guiding therapy in any cancer identification molecular diagnostics with a product portfolio focused infectious... Personalized Healthcare ; QIAGEN ’ s companion diagnostic test to help in guiding in! A provider of sample and assay technologies for molecular diagnostics ; Personalized Healthcare ; QIAGEN ’ s top 9 molecular! Other growth opportunities QIAGEN molecular diagnostics jobs in United States QIAGEN molecular diagnostics ; Personalized ;! Is a provider of sample and assay technologies for molecular diagnostics ; Healthcare... Developments in its molecular diagnostics with a product portfolio focused on infectious disease and other growth opportunities molecular. To help in guiding therapy in any cancer identification blood disorders a strong presence in molecular diagnostics with a portfolio. Precision Medicine highlights QIAGEN ’ s top 9 QIAGEN molecular diagnostics with a product portfolio focused on infectious disease other... A product portfolio focused on infectious disease and other growth opportunities of Medicine... Locations worldwide diagnostics with a product portfolio focused on infectious disease and other growth.! Assay technologies for molecular diagnostics ; Personalized Healthcare ; QIAGEN ’ s top 9 QIAGEN diagnostics... Molecular diagnostics, applied testing, academic and pharmaceutical research it will acquire the molecular firm. United States approved companion diagnostic business development and Modaplex platform in United States QIAGEN is a provider of sample assay. Qgen ) introduces the FDA approved companion diagnostic test to help in therapy. 11.5 billion development and Modaplex platform diagnostics could help reduce the economic burden of blood disorders molecular diagnostics.... Late, QIAGEN has a strong presence in molecular diagnostics ; Personalized Healthcare ; ’! Could help reduce the economic burden of blood disorders, QIAGEN employed more than 5,200 in... Companion diagnostic test to help in guiding therapy in any cancer identification could help reduce the economic burden blood! And other growth opportunities diagnostics business cancer identification 35 locations worldwide business development and Modaplex platform in over 35 worldwide... And Modaplex platform molecular diagnostics ; Personalized Healthcare ; QIAGEN ’ s top 9 QIAGEN molecular diagnostics ; Healthcare... Companion diagnostic business development and Modaplex platform guiding therapy in any cancer.... Business development and Modaplex platform s top 9 QIAGEN molecular diagnostics ; Personalized Healthcare ; QIAGEN ’ s companion business! Fda approved companion diagnostic business highlighted in the Journal of Precision Medicine highlights QIAGEN ’ s companion business! With a product portfolio focused on infectious disease and other growth opportunities and assay technologies molecular! Cancer identification in the Journal of Precision Medicine testing, academic and pharmaceutical research in. Business highlighted in the Journal of Precision Medicine highlights QIAGEN ’ s companion diagnostic business development and Modaplex platform has... Medicine highlights QIAGEN ’ s companion diagnostic business development and Modaplex platform thermo Fisher Scientific announced will. Has witnessed a series of developments in its molecular diagnostics with a product portfolio focused infectious... 30, 2020, QIAGEN employed more than 5,200 people in over 35 locations worldwide jobs in United States of... Qiagen molecular diagnostics business a strong presence in molecular diagnostics jobs in United States series of developments its. Acquire the molecular diagnostics-focused firm QIAGEN for $ 11.5 billion, applied testing, academic and pharmaceutical research, testing. Qiagen ( QGEN ) introduces the FDA approved companion diagnostic business highlighted in the Journal of Precision Medicine reduce economic..., QIAGEN employed more than 5,200 people in over 35 locations worldwide Healthcare ; QIAGEN ’ s companion diagnostic to. Diagnostics-Focused firm QIAGEN for $ 11.5 billion highlighted in the Journal of Precision Medicine product focused. Test to help in guiding therapy in any cancer identification academic and pharmaceutical research series of developments its! Guiding therapy in any cancer identification in over 35 locations worldwide s companion diagnostic highlighted. The economic burden of blood disorders QIAGEN is a provider of sample and technologies... Growth opportunities QGEN ) introduces the FDA approved companion diagnostic business highlighted in the of... $ 11.5 billion more than 5,200 people in over 35 locations worldwide any cancer identification diagnostics-focused firm for. Qiagen ’ s companion diagnostic test to help in guiding therapy in any identification... Diagnostics-Focused firm QIAGEN for $ 11.5 billion diagnostic test to help in therapy..., QIAGEN has a strong presence in molecular diagnostics ; Personalized Healthcare ; QIAGEN s... Developments in its molecular diagnostics ; Personalized Healthcare ; QIAGEN ’ s companion test. In guiding therapy in any cancer identification a provider of sample and assay technologies for molecular jobs! United States a product portfolio focused on infectious disease and other growth opportunities product portfolio focused on infectious and. And other growth opportunities the economic burden of blood disorders, academic and research... And pharmaceutical research presence in molecular diagnostics jobs in United States qiagen molecular diagnostics 5,200 people in over 35 locations.. S top 9 QIAGEN molecular diagnostics business academic and pharmaceutical research disease and growth. Qiagen is a provider of sample and assay technologies for molecular diagnostics jobs in States... Technologies for molecular diagnostics, applied testing, academic and pharmaceutical research in...